Sponsored

Switzerland has delivered some of the largest outbound Chinese acquisitions over recent years and, unlike the EU, has not imposed any formal investment restrictions. Manuel Werder, Philippe Weber, Daniel Eisele and Elga Reana Tozzi of Niederer Kraft Frey examine the market’s rules of entry

The Republic of Panama recently enacted Law 76 of February 13 2019 (Law 76 or Tax Procedure Code), through which the new tax procedure code is approved. This new Tax Procedure Code, which will come into effect on January 1 2020, does not replace the Tax Code, but rather establishes the basic principles and the fundamental rules that constitute the legal regime of the Panamanian tax system and is applicable to all national taxes.

Areej Hamada, founder of Kuwaiti law firm Legal challenges group, looks at the bridges Kuwait has been building with its largest trading partner, China, and how it has modernised its foreign investment rules

Akimoto Kawamura of Atsumi & Sakai examines Japan’s legal registration requirements for high frequency traders, investment managers and investment advisors that use fintech in Japan

A regular on lists like these, London-based Clifford Chance partner Owen Lysak advises clients on the full gamut of regulatory issues, from Mifid II to Brexit. But while many of his colleagues and contemporaries remain focused on the latter, Lysak tells IFLR that after three years of Brexit work, he's now beginning to look beyond.

Listen to a live recording of IFLR's latest webinar, in collaboration with Morrison & Foerster, featuring an overview of Brexit, updates on US regulators and discussions on EMIR and initial margin

In April, federal legislators introduced two bills in an attempt to provide the blockchain economy with regulatory certainty. Latham & Watkins’ Stephen Wink, Morgan Brubaker, Cameron Kates and Shaun Musuka investigate.

The Swiss federal government’s pre-draft DLT Act will be under public consultation until the end of June 2019. Daniel Flühmann and Peter Hsu of Bär & Karrer look at some of its most forward-thinking proposals

Baker McKenzie lawyers review the global biotech IPO landscape, considering how regulatory initiatives have aided growth